EC
KYMR icon

EcoR1 Capital’s Kymera Therapeutics KYMR Stock Holding History

EcoR1 Capital’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-350,000
Closed -$14.1M – 57
2024
Q4 		$14.1M Buy
+350,000
New +$15.8M 0.56% 34
2023
Q2 		– Sell
-796,093
Closed -$23.6M – 62
2023
Q1 		$23.6M Hold
796,093
– – 0.76% 20
2022
Q4 		$19.9M Hold
796,093
– – 0.6% 28
2022
Q3 		$17.3M Buy
+796,093
New +$21M 0.51% 29
2021
Q3 		– Sell
-519,416
Closed -$25.2M – 75
2021
Q2 		$25.2M Buy
519,416
+419,416
+419% +$18.2M 0.94% 22
2021
Q1 		$3.89M Hold
100,000
– – 0.17% 46
2020
Q4 		$6.2M Hold
100,000
– – 0.35% 36
2020
Q3 		$3.23M Buy
+100,000
New +$3.05M 0.23% 37

Other funds holding KYMR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return